PG
TEVA icon

PEAK6 Group’s Teva Pharmaceuticals TEVA Stock Holding History

PEAK6 Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,500
Closed -$197K – 4973
2018
Q1 		$197K Hold
11,500
– – ﹤0.01% 3361
2017
Q4 		$218K Sell
11,500
-67,300
-85% -$1.01M ﹤0.01% 3098
2017
Q3 		$1.39M Sell
78,800
-200,700
-72% -$4.52M 0.01% 1680
2017
Q2 		$9.29M Sell
279,500
-12,200
-4% -$378K 0.05% 410
2017
Q1 		$9.36M Sell
291,700
-142,700
-33% -$4.87M 0.08% 311
2016
Q4 		$15.7M Sell
434,400
-134,400
-24% -$5.37M 0.11% 189
2016
Q3 		$26.2M Buy
568,800
+133,700
+31% +$6.98M 0.19% 78
2016
Q2 		$21.9M Sell
435,100
-185,100
-30% -$9.85M 0.17% 110
2016
Q1 		$33.2M Buy
620,200
+37,800
+6% +$2.22M 0.27% 45
2015
Q4 		$38.2M Sell
582,400
-242,800
-29% -$15M 0.26% 43
2015
Q3 		$46.6M Buy
825,200
+492,500
+148% +$31.9M 0.24% 49
2015
Q2 		$19.7M Buy
332,700
+163,900
+97% +$10.1M 0.12% 178
2015
Q1 		$10.5M Buy
168,800
+118,700
+237% +$6.9M 0.08% 307
2014
Q4 		$2.88M Hold
50,100
– – 0.02% 1016
2014
Q3 		$2.69M Sell
50,100
-49,000
-49% -$2.6M 0.02% 1015
2014
Q2 		$5.2M Sell
99,100
-278,500
-74% -$14.2M 0.05% 501
2014
Q1 		$20M Buy
377,600
+226,900
+151% +$10.5M 0.17% 81
2013
Q4 		$6.04M Sell
150,700
-520,500
-78% -$20.5M 0.04% 596
2013
Q3 		$12.7M Buy
671,200
+469,600
+233% +$18.3M 0.09% 242
2013
Q2 		$7.9K Buy
+201,600
New +$7.85M 0.03% 434

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

PEAK6 Group's TEVA Position: Q2 2018 in Review

PEAK6 Group increased its Teva Pharmaceuticals (TEVA) stake by 681% in Q2 2018, buying an estimated $930K and bringing the position to 52,302 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1757.

PEAK6 Group first reported a position in TEVA in Q2 2013 and has held it in 18 quarters since. The position peaked at $29.2M in Q1 2014. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • PEAK6 Group held 52,302 shares of Teva Pharmaceuticals worth $1.27M as of Q2 2018.
  • PEAK6 Group bought 45,607 Teva Pharmaceuticals shares in Q2 2018, an estimated $930K.
  • Teva Pharmaceuticals made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1757 holding.
  • PEAK6 Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • PEAK6 Group's Teva Pharmaceuticals position peaked at $29.2M in Q1 2014.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.